FIC: Direct Primary Care & Drug Transparency Pass House
By: Katrina Callaway, FIC General Counsel Bills relating to direct primary care (HB 161) and drug transparency (HB 589) passed the House on March 30, 2017. There was no debate on either bill. The vote on the direct primary care bill was 107-6. The vote on the drug transparency bill was 114-0. Regarding direct primary…